Skip to content
Screener

AngioDynamics ANGO Q1 2026 earnings

Reported October 2, 2025 · Before market open

Revenue$75.7MMiss by $601.0K
EPS-$0.10Beat by $0.04
Revenue estimate$76.3M
EPS estimate-$0.14

Next report

Oct 8, 2026 (In 5 days)
Revenue estimate$80.5M
EPS estimate-$0.11

Financials

Q1 2026

Income statement

See full
Revenue$75.7M+12.2%
Gross profit$41.9M+14.0%
Operating income-$10.7M+18.6%
Net income-$10.9M+14.8%
EPS (diluted)-$0.26+16.1%

Balance sheet

See full
Cash & equivalents$38.8M-29.5%
Total debt$6.1M+12.4%
Total equity$178.9M-9.0%
Total assets$265.6M-9.5%

Cash flow

See full
Operating cash flow-$15.9M+12.8%
CapEx$731.0K-33.1%
Free cash flow-$16.6M+14.0%

Valuation & ratios

Valuation

as of 08/31/25
See full
Market cap$416.9M+38.8%
Enterprise value$384.23M+53.2%
P/S1.4×+0.4×

Profitability

See full
Gross margin54.1%+2.4pp
Operating margin-12.5%-5.7pp
Net margin-10.7%-5.0pp

Returns & leverage

See full
Return on equity-17.1%-7.5pp
Debt / equity0×0.0×
Current ratio2.3×0.0×

Segments

By product

See full
Med Device$40.5M+2.3%
Med Tech$35.3M+26.1%

FAQ

When did AngioDynamics report Q1 2026 earnings?
AngioDynamics (ANGO) reported Q1 2026 earnings on October 2, 2025 before market open.
What were AngioDynamics's Q1 2026 revenue and EPS?
AngioDynamics reported revenue of $75.7M and eps of $-0.10 for Q1 2026.
Did AngioDynamics beat estimates in Q1 2026?
Revenue missed the consensus estimate of $76.3M by $601.0K. EPS beat the consensus estimate of $-0.14 by $0.04.
How did AngioDynamics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.2% from $67.5M a year earlier and eps grew 9.1% from $-0.11.
Where can I find AngioDynamics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001140361-25-037060) and the 10-Q periodic report (0001628280-25-043689) directly on SEC EDGAR. The filing index links above go to sec.gov.